Parag Shah, PhD
Parag Shah, Ph.D. is a seasoned executive with over 20 years of experience leading strategy and operations across Portfolio/Program Management, Business Development, Pharmaceutical Science and Clinical Operations. Prior to joining Seyltx, he served as Vice President of Business Operations for Bellerophon Therapeutics, where he led the cross functional team across multiple cardiopulmonary and respiratory clinical development programs for a novel drug-device combination product. Previously, Dr. Shah was Director of Pharmaceutical Science at Ikaria where he led the Pharmaceutical Development and Clinical Supply group. Dr. Shah started his career as a Principal Scientist at Pfizer where he was responsible for leading multiple parenteral and liquid formulation development teams. Dr. Shah received his B.S. in Chemical Engineering from Carnegie Mellon University and his Ph.D. in Chemical Engineering from The University of Texas at Austin.